Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

February 1, 2021; Volume 62,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Iersel, Marleen Woltman-van

    1. You have access
      Assessment of Bone Lesions with 18F-FDG PET Compared with 99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management
      Suzanne C. van Es, Ton Velleman, Sjoerd G. Elias, Frederike Bensch, Adrienne H. Brouwers, Andor W.J.M. Glaudemans, Thomas C. Kwee, Marleen Woltman-van Iersel, John H. Maduro, Sjoukje F. Oosting, Elisabeth G.E. de Vries and Carolina P. Schröder
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 177-183; DOI: https://doi.org/10.2967/jnumed.120.244640
  2. Innis, Robert B.

    1. You have access
      11C Dosimetry Scans Should Be Abandoned
      Paolo Zanotti-Fregonara, Adriaan A. Lammertsma and Robert B. Innis
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 158-159; DOI: https://doi.org/10.2967/jnumed.120.257402
  3. Ippisch, Robin

    1. Open Access
      68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
      Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 149-155; DOI: https://doi.org/10.2967/jnumed.120.260455
  4. Ishikawa, Yoichi

    1. <sup>18</sup>F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
      You have access
      18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
      Ryuichi Harada, Yoshimi Hayakawa, Michinori Ezura, Pradith Lerdsirisuk, Yiqing Du, Yoichi Ishikawa, Ren Iwata, Miho Shidahara, Aiko Ishiki, Akio Kikuchi, Hiroyuki Arai, Yukitsuka Kudo, Kazuhiko Yanai, Shozo Furumoto and Nobuyuki Okamura
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.120.244400
  5. Ishiki, Aiko

    1. <sup>18</sup>F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
      You have access
      18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
      Ryuichi Harada, Yoshimi Hayakawa, Michinori Ezura, Pradith Lerdsirisuk, Yiqing Du, Yoichi Ishikawa, Ren Iwata, Miho Shidahara, Aiko Ishiki, Akio Kikuchi, Hiroyuki Arai, Yukitsuka Kudo, Kazuhiko Yanai, Shozo Furumoto and Nobuyuki Okamura
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.120.244400
  6. Iten, Irina

    1. You have access
      Preclinical Development of 18F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis
      Hazem Ahmed, Rahel Wallimann, Achi Haider, Vahid Hosseini, Stefan Gruber, Marvin Robledo, Thi A.N. Nguyen, Adrienne Müller Herde, Irina Iten, Claudia Keller, Viola Vogel, Roger Schibli, Bernhard Wünsch, Linjing Mu and Simon M. Ametamey
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 259-265; DOI: https://doi.org/10.2967/jnumed.120.246785
  7. Iwata, Ren

    1. <sup>18</sup>F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
      You have access
      18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
      Ryuichi Harada, Yoshimi Hayakawa, Michinori Ezura, Pradith Lerdsirisuk, Yiqing Du, Yoichi Ishikawa, Ren Iwata, Miho Shidahara, Aiko Ishiki, Akio Kikuchi, Hiroyuki Arai, Yukitsuka Kudo, Kazuhiko Yanai, Shozo Furumoto and Nobuyuki Okamura
      Journal of Nuclear Medicine February 1, 2021, 62 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.120.244400
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (2)
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
  • Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire